• General Virology
• 46 min
  1. Principles of virology

  • Prof. Vincent Racaniello
• 36 min
  2. The type I interferon system and viruses

  • Dr. Adolfo Garcia-Sastre
• 45 min
  3. Immune responses to viruses

  • Prof. Paul Klenerman
• Emerging Pathogens
• 29 min
  4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide

  • Dr. Marietjie Venter
  • Mrs. Orienka Hellferscee
• 37 min
  5. Emerging respiratory viruses - discoveries between 2001 and 2005

  • Prof. Ron Fouchier
• 28 min
  6. Usage of vaccines and therapeutics in public health emergencies 1

  • Prof. Gary Kobinger
• 39 min
  7. Usage of vaccines and therapeutics in public health emergencies 2

  • Prof. Gary Kobinger
• 50 min
  8. Influenza virus pandemics: past and future

  • Prof. Peter Palese
• 63 min
  9. SARS-CoV and other emerging coronaviruses

  • Prof. Ralph Baric
• 36 min
  10. Dengue, Zika and Chickungunya viruses

  • Prof. Ana Fernandez-Sesma
• 43 min
  11. Paramyxoviruses: biology & pathogenesis

  • Prof. Benhur Lee
• 36 min
  12. Antiviral drugs (non-HIV)

  • Prof. Megan Shaw
• 41 min
  13. Biodefense challenges

  • Dr. David Franz
• Important Pathogens and their Diseases
• 38 min
  14. Natural history and pathogenesis of herpes virus infections

  • Prof. Richard Whitley
• 40 min
  15. Cytomegalovirus biology

  • Prof. Domenico Tortorella
• 46 min
  16. Hepatitis C virus: discovery, cure and protection

  • Dr. Matthew Evans
• 32 min
  17. Fundamentals of HIV biology

  • Prof. Viviana Simon
• 44 min
  18. Measles

  • Prof. Diane E. Griffin
• 42 min
  19. Monkeypox virus, vaccines, and therapeutics

  • Prof. Rachel Roper
• New Frontiers
• 45 min
  20. HPV vaccines to prevent cervical cancer and other HPV-associated diseases

  • Dr. John Schiller
• 55 min
  21. Prevention of Varicella and Zoster by vaccination: Now you see it, now you don't

  • Prof. Anne Gershon
• 30 min
  22. Viruses as anticancer weapons

  • Prof. Roberto Cattaneo
• 48 min
  23. Novel approaches to diagnosis of viral infections

  • Prof. W. Ian Lipkin
• 36 min
  24. The Global Virus Network: collaboration to address pandemic and regional threats

  • Prof. Sten H. Vermund
• 31 min
  25. Elite controllers of HIV: from discovery to future therapies

  • Prof. Bruce Walker
• Archived Lectures *These may not cover the latest advances in the field
• 43 min
  26. Principles of virology I

  • Prof. Richard Condit
• 43 min
  27. Principles of virology II

  • Prof. Richard Condit
• 36 min
  28. Complex DNA viruses: herpes virus

  • Dr. John Blaho
• 38 min
  29. Adeno-associated viruses (AAV)

  • Prof. Kenneth Berns
• 60 min
  30. Poxviruses: smallpox (variola), vaccinia and monkeypox

  • Prof. Paula Traktman
• 26 min
  31. Can HPV testing be the sole primary cervical screening modality?

  • Prof. Jack Cuzick
• 29 min
  32. From viruses to oncolytics

  • Prof. Roberto Cattaneo
• 38 min
  33. Non HIV antivirals

  • Prof. Mary Klotman
• 42 min
  34. Gastroenteritis viruses

  • Prof. Mary Estes
• 46 min
  35. Biodefense challenges

  • Dr. Connie Schmaljohn
• 32 min
  36. Papillomaviruses and HPV vaccination to prevent cervical cancer and other HPV-associated diseases

  • Dr. Douglas Lowy
• 49 min
  37. The past, present and future of vaccination

  • Prof. Stanley Plotkin
• 41 min
  38. Filoviruses

  • Dr. Christopher Basler
• 41 min
  39. Bunyaviruses

  • Prof. Richard Elliott
• 41 min
  40. The immunobiology of HIV

  • Prof. Norman Letvin
• 59 min
  41. Hepatitis C and HCV

  • Prof. Stanley Lemon

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Edward Jenner
3. Louis Pasteur
4. Attenuated vaccines
5. Daniel Elmer Salmon
6. Inactivated vaccines
7. The immune system is redundant
8. Major licensed viral and bacterial vaccines
9. Persistence of immunity after vaccination
10. Fatal smallpox
11. Severe smallpox
12. Infants are difficult to immunize
13. Measles
14. The elderly are difficult to immunize
15. Influenza vaccine effectiveness
16. Herd immunity
17. Pediatric pneumococcal conjugate vaccination
18. Rotavirus vaccine
19. Burden of Rotavirus disease in the United States
20. Reconstructed image of the Rotavirus particle
21. Bovine (WC3) Rotavirus
22. Safety of pentavalent Rotavirus vaccine
23. G-serotype phase III safety and efficacy study
24. Influenza vaccines
25. Heterovariant protection by intranasal flu vaccine
26. Influenza vaccine efficacy
27. School-based intranasal influenza vaccination
28. Zoster vaccine
29. Herpes zoster incidence and CD4 memory
30. Study of zoster vaccine
31. Human Papillomavirus vaccine
32. HPV and cancer
33. The L1 protein
34. Gardasil: phase 3 prophylactic efficacy results
35. Newer strategies for vaccine development (1)
36. Newer strategies for vaccine development (2)
37. Parainfluenza recombinant vaccine
38. Bovine/human PIV3/RSV immunization
39. Vectors
40. CMV CTL response to Canarypox-pp65 vector
41. DNA plasmid vaccination
42. SHIV viral load
43. "Reverse vaccinology"
44. Non-parenteral routes of administration
45. TCI: antigen and adjuvant delivery via a patch
46. Methods of transcutaneous immunization
47. Macroflux(R) patch: comparison to 25 g needle
48. New meningococcal vaccines
49. Advantages of conjugated meningococcal vaccine
50. Malaria vaccines
51. Kaplan-Meier curves
52. TB vaccines
53. HIV vaccines
54. H5N1
55. Some strategies for H5N1 influenza vaccine
56. The 21st century vaccinology main problems

Topics Covered

• History of vaccines, with four lessons of vaccinology
• New vaccines, including those against rotavirus, influenza, zoster and human papillomaviruses
• New strategies of vaccine development, including recombinants, vectors, plasmid DNA and non|parenteral routes of administration

Links

Series:

• Viruses and Viral Diseases

Categories:

• Immunology
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Vaccines

Talk Citation

Publication History

• Published on October 1, 2007
• Archived on October 28, 2018

Financial Disclosures

• Stanley Plotkin consults for Sanofi, Merck, GSK, Pfizer and Takeda